MicroTransponder Receives the US FDA’s Approval for Vivistim System as the First Vagus Nerve Stimulation Implant for Stroke Rehabilitation

August 30, 2021 Auto Bot FDA, MedTech 0

Shots:

  • The approval is based on a study of 108 patients in the US and the UK, that showed patients treated with the Vivistim system had improved mobility than patients in the control group
  • The device used in conjunction with rehabilitation therapy to improve motor function in the hands & arms following ischemic stroke. The system uses an implanted pulse generator to electrically stimulate the vagus nerve, which connects the brain & abdomen and can be used in clinical settings and at home
  • The Vivistim system is a first-of-its-kind, drug-free rehabilitation system to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke using vagus nerve stimulation

Click here to­ read full press release/ article | Ref: FDA | Image: FDA

The post MicroTransponder Receives the US FDA’s Approval for Vivistim System as the First Vagus Nerve Stimulation Implant for Stroke Rehabilitation first appeared on PharmaShots.